Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy

Cabioglu N. , Onder S., Oner G., Karatay H., Ozkurt E., Trablus D. C. , ...Daha Fazla

BREAST, cilt.44, 2019 (SCI İndekslerine Giren Dergi) identifier